BRIEF published on 12/04/2025 at 15:10, 13 days 12 hours ago ACCESS Newswire Announces $1 Million Share Repurchase Program Share Repurchase Regulatory Compliance Investor Confidence Financial Strategy ACCESS Newswire
BRIEF published on 12/04/2025 at 15:10, 13 days 12 hours ago ACCESS Newswire annonce un programme de rachat d'actions d'un million de dollars. Rachat D'actions Stratégie Financière Conformité Réglementaire Confiance Des Investisseurs ACCESS Newswire
PRESS RELEASE published on 12/04/2025 at 15:05, 13 days 12 hours ago ACCESS Newswire Announces up to $1 Million Dollar Share Repurchase Program ACCESS Newswire announces approval of $1 million dollar share repurchase program. Program reflects confidence in business outlook. Company may repurchase shares based on market conditions Investor Relations Financial News Share Repurchase Program Stock Repurchase ACCESS Newswire
BRIEF published on 11/11/2025 at 14:55, 1 month 6 days ago ACCESS Newswire Inc. Reports Q3 2025 Financial Results Adjusted EBITDA Gross Margin Operating Loss Subscription Growth Q3 Revenue
BRIEF published on 11/11/2025 at 14:55, 1 month 6 days ago ACCESS Newswire Inc. publie ses résultats financiers du troisième trimestre 2025 Marge Brute EBITDA Ajusté Perte D'exploitation Croissance Des Abonnements Chiffre D'affaires Du Troisième Trimestre
PRESS RELEASE published on 11/11/2025 at 14:50, 1 month 6 days ago ACCESS Newswire Reports Third Quarter 2025 Results ACCESS Newswire Inc. (NYSE: ACCS) reports Q3 2025 revenue at $5.7M, a 2% increase YoY. Adjusted EBITDA rises 71% to $933,000 YoY. Gross margin remains strong at 75% Adjusted EBITDA Gross Margin ACCESS Newswire Q3 2025 Revenue NYSE: ACCS
BRIEF published on 11/04/2025 at 15:25, 1 month 13 days ago ACCESS Newswire to Discuss Q3 2025 Earnings on November 11 Conference Call Investor Relations Subscription Model ACCESS Newswire Q3 2025 Earnings
BRIEF published on 11/04/2025 at 15:25, 1 month 13 days ago ACCESS Newswire commentera les résultats du troisième trimestre 2025 le 11 novembre. Conférence Téléphonique Relations Avec Les Investisseurs Modèle D'abonnement ACCESS Newswire Résultats Du Troisième Trimestre 2025
PRESS RELEASE published on 11/04/2025 at 15:20, 1 month 13 days ago ACCESS Newswire to Host Third Quarter Earnings Conference Call on November 11, 2025 ACCESS Newswire Inc. to host conference call and webcast on Nov 11, 2025, at 9:00 am ET to discuss Q3 2025 results. Key topics include performance, initiatives, and subscription model shift Conference Call Forward-looking Statements Investor Relations ACCESS Newswire Q3 2025 Results
BRIEF published on 10/24/2025 at 17:30, 1 month 24 days ago ACCESS Newswire Sponsors PRSA ICON 2025 and Educators Academy Summit PRSA ICON 2025 Diamond Sponsorship Educators Academy Communications Innovation PR Solutions
Published on 12/18/2025 at 00:55, 2 hours 58 minutes ago Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 3 hours 53 minutes ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 38 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 53 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 53 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/18/2025 at 01:10, 2 hours 43 minutes ago Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 3 minutes ago Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 48 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 48 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 31 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:39, 7 hours 14 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 14 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 23 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 53 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025
